1 Market Overview
1.1 Product Overview and Scope of Gastric Cancer Testing, Treatment and Prevention
1.2 Classification of Gastric Cancer Testing, Treatment and Prevention by Type
1.2.1 Overview: Global Gastric Cancer Testing, Treatment and Prevention Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Type in 2020
1.2.3 Test
1.2.4 Treatment
1.2.5 Prevention
1.3 Global Gastric Cancer Testing, Treatment and Prevention Market by Application
1.3.1 Overview: Global Gastric Cancer Testing, Treatment and Prevention Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Gastric Cancer Testing, Treatment and Prevention Market Size & Forecast
1.5 Global Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast by Region
1.5.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Region, (2016-2021)
1.5.3 North America Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.5.4 Europe Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.5.6 South America Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Gastric Cancer Testing, Treatment and Prevention Market Drivers
1.6.2 Gastric Cancer Testing, Treatment and Prevention Market Restraints
1.6.3 Gastric Cancer Testing, Treatment and Prevention Trends Analysis
2 Company Profiles
2.1 Biogen Idec
2.1.1 Biogen Idec Details
2.1.2 Biogen Idec Major Business
2.1.3 Biogen Idec Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.1.4 Biogen Idec Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Biogen Idec Recent Developments and Future Plans
2.2 Bristol Myers Squibb
2.2.1 Bristol Myers Squibb Details
2.2.2 Bristol Myers Squibb Major Business
2.2.3 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.2.4 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bristol Myers Squibb Recent Developments and Future Plans
2.3 Eli Lilly And Company
2.3.1 Eli Lilly And Company Details
2.3.2 Eli Lilly And Company Major Business
2.3.3 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.3.4 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eli Lilly And Company Recent Developments and Future Plans
2.4 Glaxosmithkline Genentech, Inc
2.4.1 Glaxosmithkline Genentech, Inc Details
2.4.2 Glaxosmithkline Genentech, Inc Major Business
2.4.3 Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.4.4 Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Glaxosmithkline Genentech, Inc Recent Developments and Future Plans
2.5 Hoffmann-La Roche Inc.
2.5.1 Hoffmann-La Roche Inc. Details
2.5.2 Hoffmann-La Roche Inc. Major Business
2.5.3 Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.5.4 Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Hoffmann-La Roche Inc. Recent Developments and Future Plans
2.6 Immunogen Merck & Company
2.6.1 Immunogen Merck & Company Details
2.6.2 Immunogen Merck & Company Major Business
2.6.3 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.6.4 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Immunogen Merck & Company Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.7.4 Novartis Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Novartis Recent Developments and Future Plans
2.8 Pacific Edge Diagnostics Nz
2.8.1 Pacific Edge Diagnostics Nz Details
2.8.2 Pacific Edge Diagnostics Nz Major Business
2.8.3 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.8.4 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Pacific Edge Diagnostics Nz Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.9.4 Pfizer Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Roche/Genentech Oncolytics
2.10.1 Roche/Genentech Oncolytics Details
2.10.2 Roche/Genentech Oncolytics Major Business
2.10.3 Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.10.4 Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Roche/Genentech Oncolytics Recent Developments and Future Plans
2.11 Zova Biotherapeutics Inc.
2.11.1 Zova Biotherapeutics Inc. Details
2.11.2 Zova Biotherapeutics Inc. Major Business
2.11.3 Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Product and Solutions
2.11.4 Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Zova Biotherapeutics Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Gastric Cancer Testing, Treatment and Prevention Players Market Share
3.2.2 Top 10 Gastric Cancer Testing, Treatment and Prevention Players Market Share
3.2.3 Market Competition Trend
3.3 Gastric Cancer Testing, Treatment and Prevention Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue and Market Share by Type (2016-2021)
4.2 Global Gastric Cancer Testing, Treatment and Prevention Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Application (2016-2021)
5.2 Gastric Cancer Testing, Treatment and Prevention Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
6.2 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
6.3 North America Gastric Cancer Testing, Treatment and Prevention Market Size by Country
6.3.1 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2026)
6.3.2 United States Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
6.3.3 Canada Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
6.3.4 Mexico Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
7.2 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
7.3 Europe Gastric Cancer Testing, Treatment and Prevention Market Size by Country
7.3.1 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2026)
7.3.2 Germany Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7.3.3 France Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7.3.5 Russia Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
7.3.6 Italy Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
8.2 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
8.3 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Market Size by Region
8.3.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Region (2016-2026)
8.3.2 China Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.3 Japan Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.4 South Korea Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.5 India Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
8.3.7 Australia Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
9.2 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
9.3 South America Gastric Cancer Testing, Treatment and Prevention Market Size by Country
9.3.1 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2026)
9.3.2 Brazil Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
9.3.3 Argentina Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Type (2016-2026)
10.2 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2016-2026)
10.3 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Market Size by Country
10.3.1 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Country (2016-2026)
10.3.2 Turkey Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
10.3.4 UAE Gastric Cancer Testing, Treatment and Prevention Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
【掲載企業】
Biogen Idec、Bristol Myers Squibb、Eli Lilly And Company、Glaxosmithkline Genentech, Inc、Hoffmann-La Roche Inc.、Immunogen Merck & Company、Novartis、Pacific Edge Diagnostics Nz、Pfizer、Roche/Genentech Oncolytics、Zova Biotherapeutics Inc.
【免責事項】
https://www.globalresearch.jp/disclaimer